Antimicrobials
Remdesivir (RDV)

Remdesivir (RDV)

N/A
N/A
$3200/5 day course

Spectrum of Activity

Dosing

General Information

  • Early onset high risk mild-moderate COVID-19
  • Early onset moderate-severe COVID-19

Cr, ALT, AST baseline and as clinically indicated

  • Elevated LFTs, hypotension during infusion
  • Reversible AKI (animal studies)
  • Drug interaction profile unknown